The increasing interest in the European Union and the US for biosimilar drugs — low cost variants of branded biotechnology medicines, made available by enacting fresh regulatory guidelines — has prompted the Indian Pharmaceutical Export Promotion Council (Pharmexcil) to structure a biotech-specific export promotion plan.
